SGH
TTPH

Schonfeld Group Holdings’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Schonfeld Group Holdings’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-810
Closed -$121K – 358
2015
Q3 		$121K Buy
+810
New +$595K 0.06% 219

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Schonfeld Group Holdings's TTPH Position: Q4 2015 in Review

Schonfeld Group Holdings sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2015, closing a stake of 810 shares — an estimated $121K sold.

Schonfeld Group Holdings first reported a position in TTPH in Q3 2015 and held it in 1 quarter. The position peaked at $121K in Q3 2015. 105 funds tracked by Wall St. Rank hold TTPH as of Q4 2015.

  • Schonfeld Group Holdings reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Schonfeld Group Holdings sold 810 Tetraphase Pharmaceuticals, Inc. shares in Q4 2015, an estimated $121K.
  • Schonfeld Group Holdings first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2015 and held it in 1 quarter.
  • Schonfeld Group Holdings's Tetraphase Pharmaceuticals, Inc. position peaked at $121K in Q3 2015.
  • 105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2015.

Based on Schonfeld Group Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.